Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...

With its breakthrough dual-targeted natural killer cell therapy platform ... The TRAIL variant activates the death receptor (DR) pathway in cancer cells to cause additional apoptosis, maximising ...